Skip to content

Ultrasound in Detecting Lymph Node Metastasis in Older Patients Undergoing Breast Sonography

Lymph Node Evaluation in the Axilla of Symptomatic Older Women During Breast Sonography.

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01681901
Enrollment
0
Registered
2012-09-10
Start date
2006-06-07
Completion date
2007-04-30
Last updated
2017-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

This pilot clinical trial studies ultrasound in detecting lymph node metastasis in older patients with undergoing breast sonography. Diagnostic procedures, such as ultrasound, may help find breast cancer and find out how far the disease has spread

Detailed description

PRIMARY OBJECTIVES: I. To develop a reliable and consistent set of guidelines for utilizing diagnostic ultrasound to assess axillary lymph nodes for patient suspicious of breast cancer with possible nodal metastasis. SECONDARY OBJECTIVES: I. To explore whether the data collected can be used for pathologic validation of metastatic disease. OUTLINE: Patients undergo breast ultrasound.

Interventions

PROCEDUREultrasound imaging

Undergo ultrasound

Sponsors

Ohio State University Comprehensive Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients referred for a breast ultrasound * Patients who have had a mammogram with a Breast Imaging Reporting and Data System (BIRADS) of \>= 4 * Patients who are undiagnosed for breast cancer

Exclusion criteria

* Patients who have had breast cancer surgery

Design outcomes

Primary

MeasureTime frameDescription
Proportion of successful evaluations, defined as the consistent capture of the data for geometry, morphology, qualitative vascular information, and quantitative vascular information on 3 axillary lymph nodesat 15 minutes following breast sonogramThe proposed methodology will be considered unfeasible if the proportion of successful evaluations is =\< 0.7.

Secondary

MeasureTime frameDescription
Accuracy of lymph node geometry, measured with a longitudinal and transverse ratio, to determine guidelines for characterizing micro metastases to the lymph nodes3 monthsDescriptive statistics, such as means, proportions and standard deviations, will be summarized. The longitudinal-transverse ratio will be investigated for cutoff points that yield high sensitivity and to see if results are consistent with prior studies suggesting a ratio of 1.5 or less is indicative of abnormality. The percent agreement between the resulting diagnostic criteria and the surgical/pathological results will be assessed.
Accuracy of lymph node morphology, assessed for shape and echogenicity, to determine guidelines for characterizing micro metastases to the lymph nodes3 monthsDescriptive statistics, such as means, proportions and standard deviations, will be summarized. The percent agreement between the resulting diagnostic criteria and the surgical/pathological results will be assessed.
Accuracy of lymph node vascularity, assessed with color doppler, to determine guidelines for characterizing micro metastases to the lymph nodes3 monthsDescriptive statistics, such as means, proportions and standard deviations, will be summarized. The percent agreement between the resulting diagnostic criteria and the surgical/pathological results will be assessed.
Accuracy of lymphatic flow, measured with spectral doppler, to determine guidelines for characterizing micro metastases to the lymph nodes3 monthsDescriptive statistics, such as means, proportions and standard deviations, will be summarized. The percent agreement between the resulting diagnostic criteria and the surgical/pathological results will be assessed.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026